Re: Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists
- 22 September 2017
- journal article
- letter
- Published by Elsevier BV in European Journal of Cancer
- Vol. 87, 203
- https://doi.org/10.1016/j.ejca.2017.06.041
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists—a nationwide population-based cohort study based on 2010–2013 French Health Insurance dataEuropean Journal of Cancer, 2017
- Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an AntagonistEuropean Urology, 2014